Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
08/31/1993 | US5241047 Synthetic peptides and mixtures thereof for detecting HIV antibodies |
08/31/1993 | US5240959 Aranorosinol-a and aranorosinol-b produced by pseudoarachniotus roseus |
08/31/1993 | US5240705 Haemophilus paragallinarum vaccine |
08/31/1993 | US5240703 Attenuated, genetically-engineered pseudorabies virus s-prv-155 and uses thereof |
08/31/1993 | US5240696 Treatment of periodontitis |
08/31/1993 | CA1321748C Antifungal compositions and method of controlling myotic infections |
08/31/1993 | CA1321747C Antimicrobial for in-vitro diagnostic kits |
08/29/1993 | CA2090097A1 Bu-4641v, an antibacterial, antiviral and antitumor antibiotic |
08/27/1993 | WO1993017010A1 Benzodiazepinones and medicines containing them |
08/27/1993 | CA2106387A1 Benzodiazepinones |
08/25/1993 | EP0557035A2 An ester cleavage process for use with beta-lactams |
08/25/1993 | EP0556720A1 5-Aminoflavone derivatives |
08/25/1993 | EP0556521A1 Sample processing using disinfectant |
08/25/1993 | EP0556482A2 Propyl endopeptidase inhibitor |
08/25/1993 | EP0556388A1 Antiviral agent |
08/25/1993 | EP0556333A1 Avirulent microbes and uses therefor: salmonella typhi |
08/25/1993 | EP0556319A1 Sampangine and derivatives useful as antifungal agents |
08/25/1993 | EP0556292A1 Hepatitis c virus asialoglycoproteins |
08/25/1993 | EP0556182A1 Dna capable of site-specific integration into mycobacteria |
08/25/1993 | EP0483271B1 Peptides containing diamino-glycols as transition-state mimics |
08/25/1993 | EP0407452B1 Method of treating retrovirus infection |
08/24/1993 | US5239059 Ion-channel forming peptides |
08/24/1993 | US5238923 Amino-substituted heterocycles as renin inhibitors |
08/24/1993 | CA1321582C Disulfur analogs of ll-e33288 antitumor agents |
08/24/1993 | CA1321581C Ring-contracted macrolides |
08/24/1993 | CA1321580C Cephem and cepham compounds and processes for preparation thereof |
08/19/1993 | WO1993016189A1 Novel macrocyclic lactones and a productive strain thereof |
08/19/1993 | WO1993016186A1 Hybrid dna that codes for a subunit of a bacterial toxin with a hemolysin |
08/19/1993 | WO1993016095A1 Oligothionucleotides |
08/19/1993 | WO1993016037A1 N,n'-substituted imidocarbonimidic diamides derived from hydroxylamines |
08/19/1993 | WO1993015762A1 Feline infectious peritonitis vaccine and method of preparation |
08/19/1993 | WO1993015735A1 (non descriptive)-a method for delaying hiv individual aids by administration of substituted azaspirane compounds |
08/19/1993 | WO1993015608A1 Prevention of retinal injury and degeneration by specific factors |
08/19/1993 | WO1993015607A1 Ion pairs of hypericin compounds having antiviral activity |
08/19/1993 | DE4219696A1 Hybrid-dna, plasmide, oligohybridpeptid und impfstoff Hybrid dna, plasmids, and oligohybridpeptid vaccine |
08/19/1993 | CA2130090A1 Ion pairs of hypericin compounds having antiviral activity |
08/19/1993 | CA2129364A1 Oligothionucleotides |
08/19/1993 | CA2128698A1 Feline infectious peritonitis vaccine and method of preparation |
08/19/1993 | CA2128529A1 Novel macrocyclic lactones and a productive strain thereof |
08/19/1993 | CA2089544A1 Methods and compounds for the preparation of carbacephems |
08/19/1993 | CA2089540A1 Ester cleavage process for use with .beta.-lactams |
08/18/1993 | EP0556083A1 Process for the production of biologically active substances from milk and related raw materials |
08/18/1993 | EP0556051A1 Use of bilobalide and derivatives thereof for treating an infection in an individual and pharmaceutical compositions adapted for such use |
08/18/1993 | EP0555898A2 Medicaments for non-topical use |
08/18/1993 | EP0555894A1 Whooping cough vaccine |
08/18/1993 | EP0555880A2 The CD40CR receptor and ligands therefor |
08/18/1993 | EP0555769A2 Process for the preparation of Cephem-Prodrug-esters |
08/18/1993 | EP0555425A1 Antibodies to streptolysin o derivatives and variants |
08/18/1993 | EP0555421A1 Penem derivatives |
08/18/1993 | EP0555370A1 Methods and applications for efficient genetic suppressor elements |
08/18/1993 | EP0555352A1 Agents for the treatment of diseases caused by parasitic protozoa and neoplastic diseases |
08/18/1993 | EP0555347A1 SUBSTITUTED INDOLIZINO 1,2-b]QUINOLINONES |
08/18/1993 | EP0555302A1 Method of treating demyelinating disease |
08/18/1993 | EP0555291A1 Vaccinia vectors, vaccinia genes and expression products thereof |
08/18/1993 | EP0555286A1 Cell growth inhibitors |
08/18/1993 | EP0555210A1 Microbiocidal combinations of materials and their use |
08/18/1993 | EP0516660B1 Use of s-adenosyl methionine as an agent against viral infections by retroviruses |
08/18/1993 | EP0380484B1 Use of a lysozyme dimer and/or a ribonuclease dimer for th emanufacture of an antiviral or antibiotic drug |
08/18/1993 | CN1021820C Process for n-substituted adenine and n'-substituted cytimidine |
08/18/1993 | CN1021817C Novel polyamine derivatives |
08/17/1993 | US5236905 In vitro method of inhibition of HIV using transforming growth factor-.beta. |
08/17/1993 | US5236836 Catalyst for the hydrolysis of peptide bond in vasoactive intestinal peptide |
08/17/1993 | US5236708 Reduced-protein subunit vaccine for swine dysentery |
08/17/1993 | US5236706 Pharmaceutical preparation for the maturation of prothymocytes |
08/17/1993 | CA1321387C Therapeutic nucleosides |
08/17/1993 | CA1321363C Application of oligonucleotides linked to an intercalating agent, especially as a drug |
08/17/1993 | CA1321350C Method of inhibiting the transmission of aids virus |
08/17/1993 | CA1321349C Therapeutic combination of free-radical scavenger or metabolic inhibitor and biologically active protein |
08/11/1993 | EP0554446A1 Monoclonal antibodies useful in therapy of HIV-1 infection |
08/11/1993 | EP0554418A1 Intestine colonizing lactobacilli |
08/11/1993 | EP0554401A1 Neutralizing human monoclonal antibodies specific for the v3 loop and cd-4 binding site of hiv-1 gp120 |
08/11/1993 | EP0554389A1 Molecular clones of hiv-1 and uses thereof |
08/11/1993 | EP0554376A1 Dna construct for providing rna therapy |
08/11/1993 | EP0554374A1 Production and use of tracheal antimicrobial peptides |
08/11/1993 | EP0554364A1 Lipid a composition as immunogenic agents to prevent or treat gram-negative bacterial infections |
08/11/1993 | EP0554335A1 Corynebacteria and related organisms as vaccine vectors |
08/11/1993 | EP0554319A1 Antimicrobial composition |
08/11/1993 | EP0554274A1 Nucleoside derivatives |
08/11/1993 | EP0531447A4 Compositions and methods for modulating rna activity through modification of the 5' cap structure of rna |
08/11/1993 | EP0447491B1 Protoporphyrinogen inhibitors and their use in compositions for detecting and treating tumours |
08/11/1993 | CN1075146A Process for making antimicrobial quinolonyl lactams |
08/10/1993 | US5235054 3-carboxaldehyde substituted quinolines and naphthyridines |
08/10/1993 | US5234956 Reducing increase in calcium ion concenration; administering nitroglycerin, nitroprusside or derivatives thereof; treating AIDS, Alzheimer's, CNS disorders, cardiovascular disorders |
08/10/1993 | US5234913 Antiviral nucleoside combination |
08/10/1993 | CA1321196C Antiviral tricyclic benzocyclopyrimidine derivatives |
08/10/1993 | CA1321145C Pharmaceutical preparations |
08/10/1993 | CA1321144C Pharmaceutical preparations |
08/05/1993 | WO1993015207A2 Hepatitis therapeutics |
08/05/1993 | WO1993015205A2 Synthetic haemophilus influenzae conjugate vaccine |
08/05/1993 | WO1993015194A1 Enhancement of ribozyme catalytic activity by a neighboring facilitator oligonucleotide |
08/05/1993 | WO1993015187A1 Nucleozymes |
08/05/1993 | WO1993015111A1 A dna sequence and encoded polypeptide useful in the diagnosis of hepatitis disease |
08/05/1993 | WO1993015103A2 Novel steroid intermediates and processes for their preparation |
08/05/1993 | WO1993015085A1 2-isocephem and oxacephem derivatives, processes for their preparation, intermediates thereof and use as antibacterial agents |
08/05/1993 | WO1993015084A1 Novel cephalosporin compounds |
08/05/1993 | WO1993015080A1 Azabicyclo compounds as calcium channel antagonists |
08/05/1993 | WO1993015078A1 Carbapenems containing a carboxy substituted phenyl group, processes for their preparation, intermediates and use as antibiotics |
08/05/1993 | WO1993015073A1 Azabricyclic compounds as calcium channel antagonists |
08/05/1993 | WO1993015072A1 Antibacterial 1-normon-2-yl thiazolyl ketones |
08/05/1993 | WO1993014785A1 Immunotherapy for recurrent hsv infections |